Literature DB >> 30560664

A Curcumin Degradation Product, 7-Norcyclopentadione, Formed by Aryl Migration and Loss of a Carbon from the Heptadienedione Chain.

Akil I Joseph1, Paula B Luis1, Claus Schneider1.   

Abstract

Evidence that anti-inflammatory and other biological effects of curcumin may at least in part be mediated by its metabolites underscores the importance of identifying novel transformation products. Spontaneous degradation of curcumin in buffer pH 7.5 results mainly in dioxygenated products with a characteristic cyclopentadione ring composed of carbons 2 through 6 of the former heptadienedione chain. When analyzing degradation reactions of 4'- O-methylcurcumin, a product was identified missing one of the terminal carbons of the heptadienedione moiety while containing a cyclopentadione ring and adjacent hydroxy group typical of curcumin degradation products. Analysis of curcumin autoxidation reactions showed formation of an analogous compound, 7-norcyclopentadione, a degradation product exhibiting net loss of a carbon and gain of an oxygen atom. Removal of the carbon is proposed to occur via a peroxide-linked curcumin dimer in conjunction with radical-mediated 1,2-aryl migration of a guaiacol moiety. Oxidation reactions of demethoxycurcumin gave demethoxy-7-norcyclopentadione, whereas an analogous product was not observed from bis-demethoxycurcumin. Incubation of RAW264.7 macrophage-like cells with curcumin showed the presence of 7-norcyclopentadione, the formation of which was not increased upon activation of the cells with 12- O-tetradecanoylphorbol-13-acetate . 7-Norcyclopentadione is a novel type of degradation product that is most likely formed via autoxidative processes when cells are incubated with curcumin.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30560664      PMCID: PMC6474840          DOI: 10.1021/acs.jnatprod.8b00822

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  48 in total

1.  Facile synthesis of deuterated and [(14) C]labeled analogs of vanillin and curcumin for use as mechanistic and analytical tools.

Authors:  Odaine N Gordon; Leigh A Graham; Claus Schneider
Journal:  J Labelled Comp Radiopharm       Date:  2013-07-23       Impact factor: 1.921

2.  Unraveling curcumin degradation: autoxidation proceeds through spiroepoxide and vinylether intermediates en route to the main bicyclopentadione.

Authors:  Odaine N Gordon; Paula B Luis; Herman O Sintim; Claus Schneider
Journal:  J Biol Chem       Date:  2015-01-06       Impact factor: 5.157

3.  Reaction mechanism of oxidative rearrangement of flavanone in isoflavone biosynthesis.

Authors:  M F Hashim; T Hakamatsuka; Y Ebizuka; U Sankawa
Journal:  FEBS Lett       Date:  1990-10-01       Impact factor: 4.124

4.  Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis.

Authors:  Laura E Wright; Jennifer B Frye; Ashley L Lukefahr; Barbara N Timmermann; Khalid S Mohammad; Theresa A Guise; Janet L Funk
Journal:  J Nat Prod       Date:  2012-11-12       Impact factor: 4.050

5.  The anti-inflammatory activity of curcumin is mediated by its oxidative metabolites.

Authors:  Rebecca L Edwards; Paula B Luis; Paolo V Varuzza; Akil I Joseph; Sai Han Presley; Rupesh Chaturvedi; Claus Schneider
Journal:  J Biol Chem       Date:  2017-11-02       Impact factor: 5.157

6.  Effects of Stable Degradation Products of Curcumin on Cancer Cell Proliferation and Inflammation.

Authors:  Katherine Z Sanidad; Julia Zhu; Weicang Wang; Zheyuan Du; Guodong Zhang
Journal:  J Agric Food Chem       Date:  2016-11-23       Impact factor: 5.279

7.  Vanillin and ferulic acid: not the major degradation products of curcumin.

Authors:  Odaine N Gordon; Claus Schneider
Journal:  Trends Mol Med       Date:  2012-05-30       Impact factor: 11.951

8.  Application of ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry to identify curcumin metabolites produced by human intestinal bacteria.

Authors:  Yan Lou; Jinqi Zheng; Haihong Hu; Jun Lee; Su Zeng
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-01-24       Impact factor: 3.205

9.  Phase II trial of curcumin in patients with advanced pancreatic cancer.

Authors:  Navneet Dhillon; Bharat B Aggarwal; Robert A Newman; Robert A Wolff; Ajaikumar B Kunnumakkara; James L Abbruzzese; Chaan S Ng; Vladimir Badmaev; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

Review 10.  Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence.

Authors:  Ritesh Kotecha; Akiyoshi Takami; J Luis Espinoza
Journal:  Oncotarget       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.